Why donor hearts fail in cold storage — and how to prevent it

Research finds a possible solution to a common problem during cold storage transportation

12:27 AM

Author | Noah Fromson

doctors in surgery room over surgery table with cooler open with labels on it
Getty Images

Researchers have discovered a new molecular process that occurs when donor hearts are preserved in cold storage which contributes to failure after transplant, a study in both humans and animals shows.

The team, a collaboration between Michigan Medicine and Mayo Clinic, also found a therapy to reduce that damage using medication that is typically prescribed for high blood pressure. 

Investigators say the therapeutic solution can significantly improve the function of donor hearts and increase the distance they can be transported in cold storage. 

They also believe the mechanism behind the new therapy could be applied to other transplantable solid organs.

The findings are published in Nature Cardiovascular Research.

“When a donor heart is stored in the cold, physical changes occur in cardiac cells that cannot be seen by the naked eye,” said senior author Paul Tang, M.D., Ph.D., a heart transplant surgeon who conducted research with collaborators at both the University of Michigan Health Frankel Cardiovascular Center and the Mayo Clinic in Rochester, Minn.

“We observed special protein behaviors during cold preservation at the molecular level that accentuate harmful signaling and cause donor hearts to weaken following transplantation. Disrupting this process can greatly improve a donor heart’s resilience to ischemic injury and its function after transplantation.”

How donor hearts fail

During organ transport, the heart is commonly stored in a cooler after being infused with a cold preservation solution that has been used for several decades.

In the study, Tang’s team examined the molecular responses to the cold storage process at the individual cell level.

Researchers identified a promising candidate in the mineralocorticoid receptor, a protein responsible for carrying out the biological effects of hormones like aldosterone and cortisol.

When a heart is placed in cold storage, its tissue lacks oxygen and cells experience stress. Both human and animal hearts respond to this stress by signaling through MR.

Tang’s team found that during cold preservation, the receptor does not require hormones to activate. 

Instead, MR protein production greatly increases, which encourages them to cluster together into liquid droplets, or condensates, within the cell nucleus.

The process by which the proteins aggregate together from the rest of the cell is called phase separation. Investigators found that phase separation “autoactivates” the receptors and greatly increases the stress and harm for cardiac cells.

“The donor heart does not realize that we intend to transplant them into another person soon, so it is essentially turning on and supercharging the destructive cellular tools that would be better off left unused,” Tang said.

“This damage increases progressively the longer the heart is preserved. Organ transplantation is a uniquely human activity that never occurred for millions of years in nature until modern times. There is no evolutionary adaptation for this highly unusual situation.”

The inflammation and oxidative stress that occur during phase separation weaken the heart and limit its ability to pump blood. The decline is known as primary graft dysfunction and is responsible for more than one-third of deaths after heart transplant.

How to prevent donor heart failure

To stop the cycle of inflammation from damaging the donor heart, the research team needed to interrupt the MR clustering.

They accomplished this by injecting the cold preservation solution with canrenone, a water-soluble MR inhibitor that is best known as a diuretic but has important cardiac effects. 

Canrenone is commonly used in Europe to treat high blood pressure as well as chronic heart failure.

In animal and human hearts, treating them with canrenone stopped the MRs from clustering and reduced cardiac cell death. It also significantly improved donor heart function after four hours of storage, a commonly accepted preservation time threshold.

“Not only did we see improvement at a clinically acceptable threshold of four hours, but the use of canrenone displayed clinical potential of significantly extending cold preservation time beyond what we can currently achieve", said co-author Francis Pagani, M.D., Ph.D., the Otto Gago M.D. Endowed Professor in Cardiac Surgery at U-M Medical School.

The phase separation that triggers a cascade of inflammation leading to donor heart failure is seen in other organs, including the liver, kidney and lungs.

Researchers say the similar findings between mouse, pig and human hearts will allow for accelerated investigation of biotechnologies to improve organ preservation.

“It is critical that we can determine the ‘freshness’ and resilience of donor organs during preservation and transport,” said co-author Eugene Chen, M.D., Ph.D., the Frederick G. L. Huetwell Professor of Cardiovascular Medicine at University of Michigan Medical School.

“Any innovation to preserve the quality of donor organs must be vigorously pursued, and this method brings promise for the improvement of the lifesaving transplantation process.”

Additional authors: Wei Huang, M.D., Liu Liu, Ph.D., Ashraf Abou El Ela, M.D., Mulan Jiang, Jeffrey L. Platt, Ph.D., Marilia Cascalho, Ph.D., Bertram Pitt, M.D., Zhong Wang, Ph.D., and Richard M. Mortensen, M.D., Ph.D., all of University of Michigan, Ienglam Lei, Ph.D., and Hüseyin Sicim, M.D., of both U-M and Mayo Clinic, Wenbin Gao, M.D., Ph.D., Aurora Lee, M.D., and Sahar A. Saddoughi, M.D., Ph.D., all of Mayo Clinic, Emmanuel Noly, M.D., of Université de Montréal, Melissa R. Pergande, Ph.D., Mallory C. Wilson, and Ying Ge, Ph.D., all of University of Wisconsin, and Jordan S. Pober, M.D., Ph.D., of Yale University.

Funding/disclosures: This research project is supported by the National Heart, Lung, and Blood Institute (HL164416, HL166140, HL163672, HL139735, HL159871, HL134569, HL109946) and the National Institute of Allergy and Infectious Diseases (U01-AI132895, AI151588, AI173950) of the National Institutes of Health.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Paper cited: “Mineralocorticoid Receptor Phase Separation Modulates Cardiac Preservation,” Nature Cardiovascular Research. DOI: 10.1038/s44161-025-00653-x

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.  


More Articles About:

Cardiovascular: Diseases & Conditions Heart Failure Heart disease Heart Transplant Surgery Cardiovascular: Treatment & Surgery Post-Transplant Basic Science and Laboratory Research All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Francis D. Pagani

Francis D Pagani

Professor

Yuqing Chen headshot

Yuqing E Chen

Professor

Related

3DModel Chest Heart EKG purple
Health Lab

Donor hearts can be reprogrammed with medication for longer storage, improved transplant outcomes

Metabolic mechanism protects hearts from damaging metabolites that build up in cold storage, study finds
performing surgery
Health Lab

U-M Health performs its first heart transplant after cardiac death

As the number of heart transplants performed across the United States continues to grow, surgeons at the U-M Health are taking advantage of technology that could increase its transplant yield by as much as 30%. Transplant surgeons in Ann Arbor completed the health system’s first heart transplant using an organ from a donor who had recently died — a process called donation after circulatory death, or DCD.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Mother sits on a couch with a laptop on her lap while an elementary school age boy sits next to her playing on a tablet device.
Health Lab

New questionnaire aims to improve understanding of demand avoidance in children, teens

Pathological demand avoidance is a pattern of intense distress and avoidance of demands in children. A new questionnaire from University of Michigan researchers creates a structured way to assess these behaviors.
Blue round cells in three pictures showing how they change under stress.
Health Lab

Timing is of the essence for RNA during stress

Key determiners of which RNA can be read to make proteins is time. Previous thinking was that a cell under threat would quickly make these RNAs in the nucleus and immediately push them into the cytoplasm.
Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
Boy in white t-shirt, just chin showing, with hands holding a stethoscope on his chest.
Health Lab

Distance, insurance, social factors may hinder access to lifesaving heart monitoring for children

New research suggests that social, economic and geographic factors may influence whether patients who undergo the Fontan surgery for complex congenital heart disease receive the recommended lifelong cardiac monitoring.
A smartphone displaying a red heart with a white EKG line on its screen, set against a teal background.
Health Lab

Mobile health app improves heart failure medication use, dosing after hospitalization

A U-M-led trial found a mobile app improved use and dosing of recommended heart failure medications during the 90 days following a hospital discharge.